Multicenter phase II study of S-1 monotherapy as second-line chemotherapy for advanced biliary tract cancer refractory to gemcitabine

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

(2010) T Okusaka et al.   BRITISH JOURNAL OF CANCER

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer

(2009) Takashi Sasaki et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Efficacy and Safety of S-1 Monotherapy in Patients with Advanced Biliary Tract Adenocarcinoma

(2009) Inkeun Park et al.   ONCOLOGY

S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer

(2009) Takashi Sasaki et al.   ONCOLOGY

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

(2008) T André et al.   BRITISH JOURNAL OF CANCER

S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study

(2008) Junji Furuse et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY